Page last updated: 2024-09-03

gefitinib and bromochloroacetic acid

gefitinib has been researched along with bromochloroacetic acid in 1 studies

Compound Research Comparison

Studies (gefitinib)	Trials (gefitinib)	Recent Studies (post-2010) (gefitinib)	Studies (bromochloroacetic acid)	Trials (bromochloroacetic acid)	Recent Studies (post-2010) (bromochloroacetic acid)
5,231	566	2,919	22,219	258	3,378

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Astoul, P; Barlési, F; Doddoli, C; Kleisbauer, JP; Tchouhadjian, C; Torre, JP	1

Other Studies

1 other study(ies) available for gefitinib and bromochloroacetic acid

Article	Year
CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy. British journal of cancer, 2005, Jan-17, Volume: 92, Issue:1 Topics: Aged; Antigens, Neoplasm; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Gefitinib; Humans; Intracellular Signaling Peptides and Proteins; Keratin-19; Keratins; Lung Neoplasms; Male; Prognosis; Quinazolines	2005

Article

Year

CYFRA 21-1 level predicts survival in non-small-cell lung cancer patients receiving gefitinib as third-line therapy.

British journal of cancer, 2005, Jan-17, Volume: 92, Issue:1

Topics: Aged; Antigens, Neoplasm; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Female; Gefitinib; Humans; Intracellular Signaling Peptides and Proteins; Keratin-19; Keratins; Lung Neoplasms; Male; Prognosis; Quinazolines

2005